Strategic positioning MBR is a multi-specialty clinical research organization with fully owned sites and strong capabilities in Phase 1-4 cardiometabolic, endocrinology, and respiratory trials, offering sponsors reliable, centralized multi-site execution and high recruitment/retention performance.

Expansion signals Recent leadership hire of a Chief Commercial Officer and SCRS Global Impact partnership indicate a push toward enhanced market reach, business development, and industry collaboration to accelerate site partnerships and upscale study volumes.

Decision-makers Target sponsors and CROs seeking high-performing, patient-centered sites with specialized early-phase capabilities and dedicated recruitment programs to improve startup timelines and enrollment benchmarks.

Technology readiness MBR leverages modern tech and security (HIPAA-compliant stack, Cloudflare, Google Workspace, Site Kit; web presence via Elementor/Automattic) to support efficient operations, data protection, and scalable site management.

Financial profile With estimated revenue in the mid-range tens of millions, MBR presents a growth-minded partner option for mid-sized sponsors seeking proven performance at a potentially lower cost-per-study than larger CROs.